Genomic study of the tubulin-binding agent(TBA)-resistant A549 cells
碩士 === 中山醫學大學 === 醫學分子毒理學研究所 === 96 === Lung cancer is the leading cause of cancer deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for about 85 %, while SCLC accounts for the rest 15 %. The tubulin-binding agents (TBAs) are used extensively in the treatment of cancer. However, the prog...
Main Authors: | Ling-Yen, 丘翎燕 |
---|---|
Other Authors: | 許國堂 |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/94953611980690304592 |
Similar Items
-
Structural and Binding Effects of Chemical Modifications on Thrombin Binding Aptamer (TBA)
by: Vibhav Valsangkar, et al.
Published: (2021-07-01) -
Drug sensitivity profiles in neuroblastoma cells with acquired resistance to stabilising tubulin binding agents
by: Kajewole, Deborah Ifeoluwa
Published: (2014) -
Investigation of the drug resistance and metastasis in multidrug resistant lung cancer cell lines
by: Ling-Yen Chiu, et al.
Published: (2015) -
Some effects of tubulin-binding agents on behaviour
by: Clingbine, G.
Published: (1978) -
Down-regulated βIII-tubulin Expression Can Reverse Paclitaxel Resistance in A549/Taxol Cells Lines
by: Yinling ZHUO, et al.
Published: (2014-08-01)